The company
Quest Diagnostics Incorporated
DGX · NYSE
DGX stood above a rising 150-day average in 45 of the last 52 weekly readings, including each of the last 22 weeks. It is 9.8% above that average now. Diagnostics & Labs: 48% of its 44 stocks in an uptrend (−2 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 22 in a row
- Industry in uptrend
- 48% -2 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $61.9M
- Officials’ trades on record
- 45
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 45 of 52 weeks.
Diagnostics & Labs: About half its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars. Not yet read: institutions.
Congress and officials
45 disclosed lines: House 32, Senate 7, executive 6; 19 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 23 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 12 Jun 2026filed 22 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $100k–$250k | 18 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $100k–$250k | 11 May 2026filed 1 Jul 2026 |
| Alan Armstrong Senate: U.S. Senate eFDSenator | bought | $1k–$15k | 30 Mar 2026filed 21 Jul 2026 |
| Alan Armstrong Senate: U.S. Senate eFDSenator | bought | $1k–$15k | 27 Mar 2026filed 21 Jul 2026 |
| Julie Johnson House: U.S. House ClerkTX32 | soldjoint | $1k–$15k | 3 Nov 2025filed 11 Dec 2025 |
| Julie Johnson House: U.S. House ClerkTX32 | soldjoint | $1k–$15k | 30 Oct 2025filed 5 Aug 2026 |
| Julie Johnson House: U.S. House ClerkTX32 | boughtjoint | $1k–$15k | 30 Oct 2025filed 5 Aug 2026 |
| Julia Letlow House: U.S. House ClerkLA05 | sold | $1k–$15k | 24 Jul 2025filed 13 Jan 2026 |
| Julia Letlow House: U.S. House ClerkLA05 | bought | $1k–$15k | 28 Apr 2025filed 13 Jan 2026 |
| Carol D. Miller House: U.S. House ClerkWV01 | soldspouse | $15k–$50k | 10 Mar 2025filed 13 Aug 2026 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| J. E. DavisCEO and President | sold | 10,000at $242.72 | 1 Sep 2026filed 3 Sep 2026 |
| Michael E. PrevoznikSVP & General Counsel | sold | 16,010at $242.88 | 28 Aug 2026filed 31 Aug 2026 |
| Michael E. PrevoznikSVP & General Counsel | sold | 6,237at $243.63 | 28 Aug 2026filed 31 Aug 2026 |
| Michael E. PrevoznikSVP & General Counsel | sold | 430at $244.51 | 28 Aug 2026filed 31 Aug 2026 |
| Mark E. DelaneySVP & Chief Commercial Officer | sold | 1,600at $235.18 | 28 Jul 2026filed 29 Jul 2026 |
| Karthik KuppusamySVP, Clinical Solutions | sold | 8,147at $200.00 | 4 Jun 2026filed 8 Jun 2026 |
| J. E. DavisCEO and President | sold | 10,000at $194.14 | 1 Jun 2026filed 2 Jun 2026 |
| Patrick PlewmanSVP for Diagnostic Services | sold | 2,855at $206.21 | 5 Mar 2026filed 6 Mar 2026 |
| Michael E. PrevoznikSVP & General Counsel | sold | 3,878at $206.21 | 5 Mar 2026filed 6 Mar 2026 |
| Catherine T. DohertyEVP, Regional Businesses | sold | 5,558at $206.21 | 5 Mar 2026filed 6 Mar 2026 |
| Karthik KuppusamySVP, Clinical Solutions | sold | 2,628at $204.86 | 4 Mar 2026filed 6 Mar 2026 |
| Patrick PlewmanSVP for Diagnostic Services | sold | 410at $207.73 | 3 Mar 2026filed 4 Mar 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Still reading this part; it fills in a moment.
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
From its SEC filings
Analyst forecasts
No analyst forecasts yet.